EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) EBITDA Margin data is not available for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$8.43B |
|
$2.91B |
|
$2.44B |
|
$5.99B |
|
$4.42B |
|
$4.01B |
|
$-6.87M |
|
$4.01B |
|
$4.01B |
|
$2.91B |
|
$2.91B |
|
$2.91B |
|
$2.91B |
|
$4.01B |
|
$4.23B |
|
3.29B |
|
3.29B |
|
$0.88 |
|
$0.88 |
|
| Balance Sheet Financials | |
$11.66B |
|
$3.06B |
|
$4.88B |
|
$16.54B |
|
$2.75B |
|
-- |
|
$212.95M |
|
$2.97B |
|
$13.57B |
|
$13.21B |
|
$13.57B |
|
3.29B |
|
| Cash Flow Statement Financials | |
$2.59B |
|
$-1.35B |
|
$-2.06B |
|
$3.62B |
|
$2.86B |
|
$-761.12M |
|
-- |
|
$-2.01B |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
EBITDA Margin |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|